维生素D补充对注意缺陷/多动障碍儿童脑电波、行为表现、一氧化氮、丙二醛和高敏C反应蛋白影响的随机临床试验研究方案
本随机对照试验方案拟纳入50例注意缺陷/多动障碍(ADHD)儿童,双盲设计,干预组每周口服50000 IU维生素D胶囊,对照组每周口服含1000 mg橄榄油的安慰剂胶囊,共8周;评估脑电波、行为表现、血清一氧化氮、丙二醛和高敏C反应蛋白。作者认为该试验将首次评估维生素D补充对ADHD患儿上述指标的影响,为维生素D疗效提供更多视角。
要点
- ADHD患儿中部分研究显示维生素D水平低于健康人群,但相关临床试验较少。
- 本方案为双盲随机对照试验,共纳入50例ADHD患儿,干预8周。
- 干预组每周50000 IU维生素D胶囊,对照组每周1000 mg橄榄油安慰剂胶囊。
核心结论
- 作者认为该试验将首次评估维生素D补充对ADHD患儿脑电波、血清一氧化氮、丙二醛和高敏C反应蛋白的影响,结果将为维生素D在ADHD患者中的疗效提供更好视角。
研究设计与样本
- 双盲随机对照临床试验方案,拟纳入50例注意缺陷/多动障碍(ADHD)患儿。
- 干预组每周接受1粒50000 IU维生素D胶囊,共8周;对照组每周接受1粒含1000 mg橄榄油的安慰剂胶囊。
- 首次干预前及治疗10次时,使用Brain Master Discovery从19个头皮位点进行10分钟脑电图检查,并分析1分钟无伪差脑电数据用于定量脑电图测量。
- 试验于2020年11月5日在伊朗临床试验注册中心注册,注册号为IRCT20200922048802N1。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is the most common chronic mental and behavioral disorder among children. Some studies showed the lower levels of vitamin D in patients with ADHD compared with the healthy people. Few clinical trials were conducted in this field. The present study will be performed to examine the effect of vitamin D supplementation in children with ADHD. METHODS: We will conduct a double-blind, randomized controlled clinical trial to investigate the effect of vitamin D supplementation on brain waves, behavioral performance, serum nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in 50 patients with ADHD. The intervention group will receive one capsule 50,000 IU vitamin D every week, for 8 weeks. The control group will receive one placebo capsule containing 1000 mg olive oil every week. Electroencephalography will be performed for 10 min using Brain Master Discovery from 19 scalp sites both before the first intervention and the 10 sessions of the therapy. The artifact-free periods of 1-min electroencephalography data will be analyzed for quantitative electroencephalography measures. DISCUSSION: For the first time, this clinical trial will evaluate the effect of vitamin D supplementation on brain waves, serum nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in patients with ADHD. The results of the present clinical trial will provide a better vision about the vitamin D efficacy in patients with ADHD. TRIAL REGISTRATION: Registered on 5 November 2020 at Iranian Registry of Clinical Trials with code number IRCT20200922048802N1 ( https://www.irct.ir/trial/51410 ).
引用
- Sangouni AA, Mirhosseini H, Hosseinzadeh M, et al. Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial. Trials. 2022. PMID: 36273218. doi:10.1186/s13063-022-06837-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。